JP2018503629A5 - - Google Patents

Download PDF

Info

Publication number
JP2018503629A5
JP2018503629A5 JP2017535077A JP2017535077A JP2018503629A5 JP 2018503629 A5 JP2018503629 A5 JP 2018503629A5 JP 2017535077 A JP2017535077 A JP 2017535077A JP 2017535077 A JP2017535077 A JP 2017535077A JP 2018503629 A5 JP2018503629 A5 JP 2018503629A5
Authority
JP
Japan
Prior art keywords
composition
dppe
peg5000
gas
dppc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017535077A
Other languages
English (en)
Japanese (ja)
Other versions
JP6728186B2 (ja
JP2018503629A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/067615 external-priority patent/WO2016109400A2/en
Publication of JP2018503629A publication Critical patent/JP2018503629A/ja
Publication of JP2018503629A5 publication Critical patent/JP2018503629A5/ja
Application granted granted Critical
Publication of JP6728186B2 publication Critical patent/JP6728186B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017535077A 2014-12-31 2015-12-28 脂質カプセル化ガスマイクロスフェア組成物および関連方法 Expired - Fee Related JP6728186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462098453P 2014-12-31 2014-12-31
US62/098,453 2014-12-31
PCT/US2015/067615 WO2016109400A2 (en) 2014-12-31 2015-12-28 Lipid-encapsulated gas microsphere compositions and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020113906A Division JP2020172507A (ja) 2014-12-31 2020-07-01 脂質カプセル化ガスマイクロスフェア組成物および関連方法

Publications (3)

Publication Number Publication Date
JP2018503629A JP2018503629A (ja) 2018-02-08
JP2018503629A5 true JP2018503629A5 (https=) 2019-02-14
JP6728186B2 JP6728186B2 (ja) 2020-07-22

Family

ID=56285147

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017535077A Expired - Fee Related JP6728186B2 (ja) 2014-12-31 2015-12-28 脂質カプセル化ガスマイクロスフェア組成物および関連方法
JP2020113906A Withdrawn JP2020172507A (ja) 2014-12-31 2020-07-01 脂質カプセル化ガスマイクロスフェア組成物および関連方法
JP2023064692A Withdrawn JP2023089124A (ja) 2014-12-31 2023-04-12 脂質カプセル化ガスマイクロスフェア組成物および関連方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020113906A Withdrawn JP2020172507A (ja) 2014-12-31 2020-07-01 脂質カプセル化ガスマイクロスフェア組成物および関連方法
JP2023064692A Withdrawn JP2023089124A (ja) 2014-12-31 2023-04-12 脂質カプセル化ガスマイクロスフェア組成物および関連方法

Country Status (16)

Country Link
US (5) US10583207B2 (https=)
EP (2) EP3240579B1 (https=)
JP (3) JP6728186B2 (https=)
KR (2) KR20240005184A (https=)
CN (2) CN107206111B (https=)
AU (2) AU2015374286B2 (https=)
BR (1) BR112017013787A2 (https=)
CA (1) CA2972423A1 (https=)
EA (1) EA201791437A1 (https=)
ES (1) ES2928401T3 (https=)
IL (2) IL252705B2 (https=)
MX (3) MX2017008721A (https=)
NZ (1) NZ733010A (https=)
TW (2) TWI821755B (https=)
WO (1) WO2016109400A2 (https=)
ZA (1) ZA201704426B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3240579B1 (en) 2014-12-31 2022-07-27 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
MX2018013409A (es) * 2016-05-04 2019-07-08 Lantheus Medical Imaging Inc Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP4267203A1 (en) * 2020-12-27 2023-11-01 Solstice Pharmaceuticals B.V. A cartridge for mixing a phospholipid composition intended for intracorporeal use

Family Cites Families (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873564A (en) 1971-03-03 1975-03-25 Synvar Ass 2-Imidazolinyl-3-oxide-1-oxypropionic acid
CH588887A5 (https=) 1974-07-19 1977-06-15 Battelle Memorial Institute
CH621479A5 (https=) 1977-08-05 1981-02-13 Battelle Memorial Institute
CH624011A5 (https=) 1977-08-05 1981-07-15 Battelle Memorial Institute
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
WO1982001642A1 (en) 1980-11-17 1982-05-27 Med Inc Ultra Microbubble precursors and methods for their production and use
DE3141641A1 (de) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
SE463651B (sv) 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
JPH0753661B2 (ja) 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
EP0231091B1 (en) 1986-01-24 1993-03-31 Children's Hospital Medical Center Stable emulsions of highly fluorinated organic compound
JPS6360943A (ja) 1986-09-01 1988-03-17 Green Cross Corp:The 超音波診断造影剤
FR2608942B1 (fr) 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
FR2634375B3 (fr) 1988-06-30 1991-07-05 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
US5219538A (en) 1987-03-13 1993-06-15 Micro-Pak, Inc. Gas and oxygen carrying lipid vesicles
JPS63277618A (ja) 1987-03-31 1988-11-15 Noebia:Kk リポソ−ムの製造方法
CH672733A5 (https=) 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
IE61591B1 (en) 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
DE3803972A1 (de) 1988-02-05 1989-08-10 Schering Ag Ultraschallkontrastmittel
DE3812816A1 (de) 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
US5171755A (en) 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5045304A (en) 1988-08-31 1991-09-03 Wayne State University Contras agent having an imaging agent coupled to viable granulocytes for use in magnetic resonance imaging of abscess and a method of preparing and using same
GB8824593D0 (en) 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
FR2649335B1 (fr) 1989-07-05 1991-09-20 Texinfine Sa Procede et dispositif de production directe de liposomes
US5843473A (en) 1989-10-20 1998-12-01 Sequus Pharmaceuticals, Inc. Method of treatment of infected tissues
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5209720A (en) 1989-12-22 1993-05-11 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5088499A (en) 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5228446A (en) 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5149319A (en) 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5230882A (en) 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5123414A (en) 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5352435A (en) 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5705187A (en) 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
IN172208B (https=) 1990-04-02 1993-05-01 Sint Sa
ES2138122T3 (es) 1990-04-10 2000-01-01 Imarx Pharmaceutical Corp Polimeros como medios de contraste para resonancia magnetica.
US5368840A (en) 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
US5358702A (en) 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
GB9106673D0 (en) 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
WO1992022298A1 (en) 1991-06-18 1992-12-23 Unger Evan C Novel liposomal drug delivery systems
US5409688A (en) 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
HU218018B (hu) 1991-09-17 2000-05-28 Sonus Pharmaceuticals Inc. Gázos ultrahang-kontrasztanyag és eljárás ultrahang kontrasztanyaghoz megfelelő gázok kiválasztására
MX9205298A (es) 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
AU2789192A (en) 1991-10-04 1993-05-03 Mallinckrodt Medical, Inc. Gaseous ultrasound contrast agents
GB9200387D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
EP0680341B1 (en) 1993-01-25 2001-05-09 Sonus Pharmaceuticals, Inc. Phase shift colloids as ultrasound contrast agents
US5558855A (en) 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
GB9305349D0 (en) 1993-03-16 1993-05-05 Nycomed Imaging As Improvements in or relating to contrast agents
GB9305351D0 (en) 1993-03-16 1993-05-05 Nycomed Imaging As Improvements in or relating to contrast agents
DE4313402A1 (de) 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
EP1550464A1 (en) 1993-07-30 2005-07-06 IMCOR Pharmaceutical Co. Stabilized microbubble composition for ultrasound
GB9318288D0 (en) 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
ES2152990T3 (es) 1993-09-09 2001-02-16 Schering Ag Principios activos y microparticulas que contienen gases.
AU683957B2 (en) 1993-11-05 1997-11-27 Amgen, Inc. Liposome preparation and material encapsulation method
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
CN1068229C (zh) 1993-12-15 2001-07-11 勃勒柯研究有限公司 超声对比介质、含该介质的对比剂及方法
NO940711D0 (no) 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
KR970701551A (ko) 1994-03-11 1997-04-12 고야 마사시 리포좀 제제(liposome preparation)
WO1995026205A1 (en) 1994-03-28 1995-10-05 Nycomed Imaging A/S Liposomes
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6066331A (en) 1994-07-08 2000-05-23 Barenholz; Yechezkel Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
US5562893A (en) 1994-08-02 1996-10-08 Molecular Biosystems, Inc. Gas-filled microspheres with fluorine-containing shells
JPH08151335A (ja) 1994-09-27 1996-06-11 Otsuka Pharmaceut Co Ltd 超音波造影剤およびその製造方法
US5540909A (en) 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5558092A (en) 1995-06-06 1996-09-24 Imarx Pharmaceutical Corp. Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
CA2218541A1 (en) 1995-06-07 1996-12-19 Imarx Pharmaceutical Corp. Novel targeted compositions for diagnostic and therapeutic use
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US5897851A (en) 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
WO1997040679A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US6214375B1 (en) * 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
US5837221A (en) 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
WO1998010798A1 (en) 1996-09-11 1998-03-19 Imarx Pharmaceutical Corp. Improved methods for diagnostic imaging using a contrast agent and a vasodilator
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
TR199901544T2 (xx) 1996-10-21 1999-09-21 Nycomed Imaging As Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
EP0963209A2 (en) 1996-10-28 1999-12-15 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
BR9713978A (pt) 1996-10-28 2000-05-02 Nycomed Imaging As Agente diagnóstico alvejável e/ou terapeuticamente ativo, processo para preparação e uso do mesmo, formulação combinada, e, processos para gerar imagens intensificadas de um corpo animal humano ou não-humano e para investigação in vitro de alvejamento por um agente
EP0973552B1 (en) 1996-10-28 2006-03-01 Amersham Health AS Improvements in or relating to diagnostic/therapeutic agents
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9717588D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
ES2244169T3 (es) 1998-02-09 2005-12-01 Bracco International B.V. Suministro direccionado de medios biologicamente activos.
US6572840B1 (en) * 1999-07-28 2003-06-03 Bristol-Myers Squibb Pharma Company Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
CA2437217C (en) 2001-02-02 2015-06-16 Bristol-Myers Squibb Pharma Company Apparatus and methods for on-line monitoring of fluorinated material in headspace of vial
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
CN102600485B (zh) 2004-06-04 2014-10-22 阿库斯菲尔公司 超声对比剂剂量配方
EP1793919A4 (en) * 2004-09-03 2009-12-23 Imarx Therapeutics Inc DEVICE AND METHOD FOR PRODUCING A MICROSPHERIC COMPOSITE COMPOSITION
CN101229382A (zh) * 2008-02-04 2008-07-30 许川山 一种适用于多种成像模式的新型造影剂
US8459462B2 (en) 2008-10-10 2013-06-11 Quest Diagnostics Investments Incorporated System and method for sorting specimen
JP5347714B2 (ja) 2009-05-26 2013-11-20 三菱電機株式会社 映像情報再生方法及び映像情報再生装置
JP2012213475A (ja) 2011-03-31 2012-11-08 Panasonic Corp 超音波造影剤注入装置
US9101895B2 (en) 2011-04-15 2015-08-11 General Electric Company System for mixing and dispersing microbubble pharmaceuticals
US10279053B2 (en) 2011-07-19 2019-05-07 Nuvox Pharma Llc Microbubble compositions, method of making same, and method using same
EP2748299B1 (en) * 2011-08-24 2018-03-14 The Regents of The University of California Targeting microbubbles
JP2015002752A (ja) 2011-12-09 2015-01-08 パナソニック株式会社 薬剤容器
WO2014015186A1 (en) 2012-07-18 2014-01-23 Labminds Ltd. Automated solution dispenser
WO2014124440A2 (en) 2013-02-11 2014-08-14 Bloch Andrew E Apparatus and method for providing asymmetric oscillations
WO2014144364A1 (en) 2013-03-15 2014-09-18 Children's Medical Center Corporation Gas-filled stabilized particles and methods of use
EP2787352A1 (en) 2013-04-05 2014-10-08 F. Hoffmann-La Roche AG Analysis system for a biological sample
TWI552761B (zh) 2013-05-03 2016-10-11 博信生物科技股份有限公司 一種脂質微/奈米氣泡、及其最佳化之製備方法及製備裝置
TWI504413B (zh) 2013-07-24 2015-10-21 Univ Nat Chiao Tung 奈米級複合高分子顯影劑及藥物載體
GB201405735D0 (en) 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
US9801959B2 (en) 2014-06-12 2017-10-31 Microvascuar Therapeutics Llc Phospholipid composition and microbubbles and emulsions formed using same
KR20230015509A (ko) 2014-10-30 2023-01-31 랜티우스 메디컬 이메징, 인크. 지질 캡슐화된 기체 마이크로스피어 조성물 및 관련된 방법
EP3240579B1 (en) 2014-12-31 2022-07-27 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
MX2018013409A (es) 2016-05-04 2019-07-08 Lantheus Medical Imaging Inc Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
CN116261470A (zh) 2020-08-04 2023-06-13 蓝瑟斯医学影像公司 用于制备超声波造影剂的方法和装置
TW202342111A (zh) 2022-02-09 2023-11-01 美商藍瑟斯醫學影像公司 氣體奈米/微泡組合物及其用途

Similar Documents

Publication Publication Date Title
CN107106692B (zh) 磷脂组合物和微囊及使用磷脂组合物和微囊形成的乳剂
JP6913458B2 (ja) 抗菌水
JP2018503629A5 (https=)
EP4309657A3 (en) Remote loading of sparingly water-soluble drugs into liposomes
BR112014027116A2 (pt) formulação de anticorpo
JP2018506575A5 (https=)
JP6094388B2 (ja) ペメトレキセドを含む注射用組成物
JP2018021007A5 (https=)
RU2017146716A (ru) Способ образования наночастиц циклоспорина а/ циклодекстрина
JP2016539921A5 (https=)
JP2019509311A5 (https=)
WO2014144295A4 (en) Ceftolozane antibiotic compositions
TWI813571B (zh) 防沉澱的小分子藥調配物
JP2016503058A5 (https=)
WO2019080193A1 (zh) 一种包封游离虾青素的脂质体及其制备方法
CN108883204A (zh) 脂质微泡及其制备方法
Kutscher et al. Inhalational Delivery of β‐glucan‐chitosan‐poly (lactic co‐glycolic) acid Nanoparticles Enhance Alveolar Macrophage Rifampin Concentrations for the Treatment of Tuberculosis
CN102764456B (zh) 血管栓塞剂及其用途、制备方法
CN102973505A (zh) 一种阿苯达唑纳米乳及其制备方法
JP2017014153A (ja) ペメトレキセドを含有する注射用溶液製剤
Ghoneim et al. Spray-dried silica xerogel nanoparticles as a promising gastroretentive carrier system for the management of chemotherapy-induced nausea and vomiting
CZ242196A3 (en) Gas-containing micro-particles, preparation containing such micro-particles, their use in ultrasonic diagnostics and process for preparing both the micro-particles and the preparation
JP2015040185A (ja) 造影用組成物
WO2019131723A1 (ja) 薬物の投与方法
WO2016005995A2 (en) Glycol free stable liquid compositions of bendamustine